Laurus Labs Ltd. (LAURUSLABS)
BSE
2,032.10
+32.10 (+1.60%)
Closed
Oct 9, 2026
Day's Range
1,988.602,048.00
52 wk Range
843.302,063.95
Financial Statements - LAURUSLABS - Laurus Labs Ltd.
Revenue
67.21B▲ 22.0%
Net Income
8.90B▲ 148.4%Net Margin 13.2%
EBITDA
18.29B▲ 72.0%
Free Cash Flow
5.53B▲ 1506.7%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 67.21B | 55.07B | 50.01B | 60.14B | 48.88B | 47.23B |
| Cost of Goods | 27.63B | 25.39B | 24.99B | 28.40B | 22.48B | 21.97B |
| Gross Profit | 39.57B | 29.68B | 25.02B | 31.73B | 26.40B | 25.25B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 13.06B | 6.25B | 3.94B | 12.93B | 11.72B | 13.46B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 11.81B | 4.84B | 2.36B | 11.08B | 10.83B | 13.01B |
| Income Tax | 2.92B | 1.29B | 681.50M | 3.12B | 2.51B | 3.17B |
| Net Income | 8.90B | 3.58B | 1.62B | 7.93B | 8.32B | 9.83B |
| EPS Basic | 16.47 | 6.65 | 2.98 | 14.69 | 15.42 | 18.36 |
| EPS Diluted | 16.45 | 6.64 | 2.97 | 14.64 | 15.35 | 18.28 |
| Basic Shares Outstanding | 539.73M | 539.15M | 538.74M | 537.73M | 536.81M | 535.74M |
| Diluted Shares Outstanding | 539.73M | 539.15M | 538.74M | 537.73M | 536.81M | 535.74M |
| Ebit | 13.42B | 6.90B | 4.08B | 12.31B | 11.59B | 13.56B |
| Ebitda | 18.29B | 10.63B | 7.77B | 15.55B | 14.10B | 15.62B |
| Net Income Continuous Operations | 11.81B | 4.84B | 2.36B | 11.08B | 10.83B | 13.01B |
| Minority Interests | -13.50M | -200K | -17.20M | -33.20M | -47.10M | -2.40M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
